Different procedures have been used in attempts to increase the production of interferon by polyriboinosinic acid-polyribocytidylic acid (poly [rI] juvant, COAM, endotoxin and Brucella abortus) on both toxicity and interferon production by poly (rI) -poly (rC) in mice and found that, with all systems tested, no increase in interferon production could be achieved without a concomitant rise in toxicity. Our results strongly suggest that the in vivo interferon-inducing and toxic effects of poly (rI) -poly (rC) are linked phenomena and that it might be impossible to improve the therapeutic ratio (ratio of maximum tolerated dose to minimum effective dose) of poly (rI) -poly (rC).
In view of the potential importance of polyriboinosinic acid-polyribocytidylic acid (poly [rI] . poly [rC] ) as an interferon inducer and antiviral agent in clinical medicine, numerous attempts have been undertaken to increase its antiviral activity or decrease its toxicity, or both.
Several procedures are known to increase the in vivo interferon-inducing capacity of poly (rI) -poly (rC): (i) complex formation of the polynucleotide with high-molecular-weight polycations such as diethylaminoethyl (DEAE)-dextran (9, 10) or poly-D-lysine (18, 19) ; (ii) simultaneous injection of lead acetate (21) ; (iii) simultaneous injection of cycloheximide (6, 26) ; and (iv) prior injection of Freund's adjuvant (7) or polyacetal carboxylates such as chlorite-oxidized oxyamylose (COAM) (H. B. Levy, Int. Colloq. on Interferon and Interferon Inducers, Leuven, Belgium, 1971) . Some of these procedures have also been shown to enhance the toxicity of poly (rI) -poly (rC) in vivo: simultaneous injection of lead acetate (1) ; other conditions known to produce enhancement of toxicity are simultaneous injection of actinomycin D (17) and adrenalectomy (27) .
We have now directly compared the effects of several of these and other factors (lead acetate, cycloheximide, actinomycin D, Freund's ad-1 "Aangesteld Navor-ser" of the Belgian National Foolds voor Wetenschappelijk Onder-zoek. juvant, COAM, endotoxin and Brucella abortus) on both toxicity and interferon production by poly (rI) -poly (rC) in mice and found that, with all systems tested, no increase in interferon production could be achieved without a concomitant rise in toxicity. Our results strongly suggest that the in vivo interferon-inducing and toxic effects of poly (rI) -poly (rC) are linked phenomena and that it might be impossible to improve the therapeutic ratio (ratio of maximum tolerated dose to minimum effective dose) of poly (rI) -poly (rC).
MATERIALS AND METHODS
Animals. Female NMRI mice, weighing 10 to 12 g, were used throughout our experiments. They were housed in an air-conditioned room at 25 C and given food and water ad libitum.
Compounds. Poly (rl) -poly (rC) was prepared by mixing the individual homopolymers (both purchased from P-L Biochemicals, Inc., Milwaukee, Wis.) in equal amounts (2.5 mg/ml) in buffered saline (0.15 M NaCl) and allowing them to react for 1 hr at 45 C. Samples of the stock solutions were stored at -20 C. Before use a sample was thawed and diluted in phosphate-buffered saline to the appropriate concentration. Poly (rI) -poly (rC) was injected intravenously. Lead Lethality and interferon production by poly (rI) -poly (rC) were also determined in mice treated with cycloheximide or COAM (Fig. 2 ). These mice were tested for circulating interferon 8 hr after injection of poly (rI) -poly (rC). Blood samples were taken at 8 hr (instead of 2 hr) for two reasons: (i) in mice treated with cycloheximide, serum interferon levels reach their peak value at 8 hr after injection of the polynucleotide and, (ii) in mice treated with COAM, residual interferon production, due to COAM itself, which is injected 24 hr before poly (rI) poly (rC), is minimal at 8 hr after injection of the polynucleotide. Both COAM injected intra- Mg of poly (rI) -poly (rC) per mouse from 10 to 80%, as did endotoxin, whereas actinomycin D brought about the same shift in lethality as observed with cycloheximide (see Fig. 2 ), but neither B. abortus nor endotoxin nor actinomycin D brought about a significant increase in the interferon response to poly (rI) -poly (rC), whether interferon production was measured 2 hr (with B. abortus and endotoxin) or 8 hr (with actinomycin D) after injection of the polynucleotide. DISCUSSION There is ample evidence that poly (rI)-poly (rC) is a toxic substance sharing many of the toxic properties of bacterial endotoxins. Poly (rI) poly (rC) is lethal for mice at relatively low dosages ( Fig. 1 and 2) , provokes a local Shwartzman phenomenon (1), is highly pyrogenic (13) and embryotoxic (2) in rabbits, exerts a toxic effect on the hemopoietic stem cells in mice (11) , induces allogeneic (runt-like) disease in mice and rats (thymic atrophy, spleen hypoplasia, lymphopenia) (12) , and accelerates the onset of autoimmune disease in New Zealand mice (20) . Ocular toxicity (lens opacification, iris hyperemia, aqueous flare) has been reported with poly (rI) poly (rC) in rabbits (16) and cerebellar toxicity (edema, hemorrhage, ataxia, due to destruction of the endothelial cells of the small blood vessels) has been reported in chickens (25) .
Attempts have been made to increase the activity-to-toxicity ratio of poly (rI) -poly (rC) by decreasing its molecular weight, but the antiviral activity appeared to decline with decreases in homopolymer molecular weight at approximately the same rate as the acute toxicity (15) . The data presented here clearly indicate that with poly (rI) -poly (rC) no significant separation of toxicity from interferon production (or antiviral activity, since interferon production accounts for the whole antiviral activity of poly [rI] .poly [rC] in certain well defined experimental conditions [8] ) can be achieved.
Four different procedures enhanced the interferon-inducing capacity of poly (rI) -poly (rC): prior injection of Freund's adjuvant or COAM and simultaneous injection of lead acetate and cycloheximide. Although these procedures may alter a comparable basic parameter in interferonproducing cells, they are thought to increase interferon production by different mechanisms: Freund's adjuvant, by a stimulatory effect on the phagocytic activity of the lymphoreticular system (7); cycloheximide, by inhibition of the synthesis of a regulatory protein (repressor) which prevents interferon production (24) , or, by stimulation of the release of previously cleared interferon (4). The mechanism by which lead acetate and COAM increase the interferon response to poly (rI) -poly (rC) is not clear. The enhancing effect of lead acetate on the toxicity of endotoxin has been ascribed to an inactivation of the sulfhydryl groups of enzymes involved in the detoxification of endotoxin (3) . The priming effect of COAM on the activity of poly (rI) -poly (rC) might be related to a stimulatory effect on some functional activities of the lymphoreticular system; other polycarboxylates such as polymethacrylic acid (E. De Clercq and P. De Somer, unpublished data) and pyran copolymer (14) have also been shown to sensitize animals for the interferon-inducing and lethal effects of endotoxin. All four systems used (Freund's adjuvant, lead acetate, cycloheximide, and COAM) increased interferon production and toxicity of poly (rI) -poly (rC) in parallel. From these results it seems likely that the antiviral activity of poly (rI) -poly (rC) cannot be increased without a concomitant increase in toxicity.
Three other procedures (actinomycin D, endotoxin, and B. abortus) increased the lethality of poly (rI) -poly (rC) without increasing the interferon response to the polynucleotide. Actinomycin D was injected simultaneously with poly (rI) -poly (rC), whereas endotoxin and B. abortus were injected 6 and 24 hr, respectively, before the polynucleotide. It is possible, however, that some modifications in these time intervals might have caused an increase in interferon production proportional to the increased toxicity.
It has been proposed (22) 
